Medicine Supply Notification: Salbutamol 100micrograms/dose breath actuated inhalers CFC free
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following product:
- Salbutamol 100micrograms/dose breath actuated inhalers CFC free
MSN/2025/041
Tier 2 – medium impact
Date of issue: 04/07/2025
- Salbutamol (Salamol Easi-Breathe®) 100micrograms/dose breath actuated inhaler CFC free is out of stock until mid-September 2025; following resupply, stock will be limited until December 2025.
- Salbutamol (Airomir®) 100micrograms/dose breath actuated inhaler CFC free has been discontinued.
- Salbutamol (Salamol®) 100micrograms/dose inhaler CFC free pressurised metered-dose inhaler (pMDIs) remains available and can support increased demand.
- Salbutamol (Easyhaler®) 100micrograms/dose dry powder inhaler (DPI) remains available and can support increased demand.
- Salbutamol (Ventolin Evohaler®) 100microgram/dose inhaler CFC free pMDI and salbutamol (Salbulin Novolizer®) 100micrograms/dose inhalation powder remain available however cannot support any increase in demand.
A copy of this medicine supply notification, including actions required and supporting information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool.
The Tool also details any changes to resupply dates and updates to the entries.
To access the Tool, you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website can be reported using our shortage reporting tool.
